These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17086150)

  • 1. [Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine].
    Maiga Y; Nogues B; Guillon B
    Rev Neurol (Paris); 2006 Nov; 162(11):1125-7. PubMed ID: 17086150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
    Biraben A; Allain H; Scarabin JM; Schück S; Edan G
    Neurology; 2000 Dec; 55(11):1758. PubMed ID: 11113246
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile myoclonic epilepsy.
    Alfradique I; Vasconcelos MM
    Arq Neuropsiquiatr; 2007 Dec; 65(4B):1266-71. PubMed ID: 18345445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA; García VF; Astencio AG; Cuartas VB
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy with myoclonic absences.
    Surve TY; Mittal G; Khadse SS; Khanna SA
    Indian J Pediatr; 2006 Feb; 73(2):151-2. PubMed ID: 16514226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Juvenile myoclonic epilepsy].
    Syvertsen MR; Markhus R; Selmer KK; Nakken KO
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1610-3. PubMed ID: 22875125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
    Morris GL; Hammer AE; Kustra RP; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis rosea-like eruption associated with lamotrigine.
    Papadavid E; Panayiotides I; Makris M; Giatrakou S; Dalamaga M; Stavrianeas N; Rigopoulos D
    J Am Acad Dermatol; 2013 Jun; 68(6):e180-1. PubMed ID: 23680210
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
    Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
    Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
    Carrazana EJ; Wheeler SD
    Neurology; 2001 May; 56(10):1424-5. PubMed ID: 11376212
    [No Abstract]   [Full Text] [Related]  

  • 14. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A; Velizarova R; Genton P; Gélisse P
    Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected lamotrigine-induced toxic epidermal necrolysis.
    Söğüt A; Yilmaz A; Kilinç M; Söğüt AG; Demiralay E; Uzar H
    Acta Neurol Belg; 2003 Jun; 103(2):95-8. PubMed ID: 12892003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of juvenile myoclonic epilepsy.
    Auvin S
    CNS Neurosci Ther; 2008; 14(3):227-33. PubMed ID: 18684236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile myoclonic epilepsy.
    Buchanan N
    J Paediatr Child Health; 1995 Aug; 31(4):267-8. PubMed ID: 7576878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic management of seizures in the syndromes of idiopathic generalized epilepsy.
    Bourgeois BF
    Epilepsia; 2003; 44 Suppl 2():27-32. PubMed ID: 12752459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.